Modulation of apoptosis and immune response by synbiotic in experimental colorectal cancer

International Journal of Pharma and Bio Sciences

Volumn 6, Issue 3, 2015, Pages B529-B543

  Verma, Angela ^a   Shukla, Geeta ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Apoptosis; Colon; Prebiotic; Probiotic; Synbiotic

Indexed keywords

1,2 DIMETHYLHYDRAZINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; INULIN; K RAS PROTEIN; PROBIOTIC AGENT; PROTEIN BCL 2; PROTEIN P53; SYNBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER PREVENTION; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOMODULATION; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS RHAMNOSUS; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; TISSUE LEVEL; TREATMENT DURATION;

ANIMALIA; RATTUS;

EID: 85051684991     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Parkin DM., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin, 55:74-108, (2005).
2. Jemal A., Bray F., Center MM., Ferley J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin, 61:69-90, (2011).
3. Watson AJ., Pritchard DM. Lessons from genetically engineered animal models. VII. Apoptosis in intestinal epithelium: lessons from transgenic and knockout mice. Am J Physiol Gastrointest Liver Physiol, 278:G1-5, (2000).
4. Rajagopalan H., Nowak MA. Vogelstein B., Lengauer C. The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer, 3: 695-701, (2003).
5. Bedi A., Zehnbauer BA., Barber JP., Sharkis SJ., Jones RJ. Inhibition of apoptosis during development of colorectal-cancer. Cancer Res, 55:1811-1816, (1994).
6. Kukitsu T., Takayama T., Miyanishi K., Nobuoka A., Katsuki S., Sato Y., Takimoto R., Matsunaga T., Kato J., Sonoda T., Sakamaki S., Niitsu Y. Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis. Clin Cancer Res, 14: 48-54, (2008).
7. Kumar KS., Sastry N., Polaki H., Mishra V. Colon cancer prevention through probiotics: an overview. Cancer Sc Ther, 7(2):081-092, (2015).
8. Iyer C., Kosters A., Sethi G., Kunnumakkara AB., Aggarwal BB., Versalovic J. Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kappaB and MAPK signalling. Cell Microbiol, 10:1442-1452, (2008).
9. Otte JM., Mahjurian-Namari R., Brand S., Werner I., Schmidt WE., Schmitz F. Probiotics regulate the expression of COX-2 in intestinal epithelial cells. Nutr Cancer, 61:103-113, (2009).
10. Dai C., Zheng C-Q., Meng F-J., Zhou Z., Sang L-X., Jiang M. VSL#3 probiotics exerts the anti-inflammatory activity via PI3k/Akt and NF-kB pathway in rat model of dss-induced colitis. Mol Cell Biochem, 374: 1-11, (2013).
11. Duary RK., Bhausaheb MA., Batish VK., Grover S. Antiinflammatory and immunomodulatory efficacy of indigenous probiotic Lactobacillus plantarum Lp91 in colitis mouse model. Mol Biol Rep, 39:4765-4775, (2012).
12. Bron PA., van Baarlen P., Kleerebezem M. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol, 10:66-78, (2012).
13. Sivieri K., Bedani R., Cavallini DCU., Rossi EA. Probiotics and intestinal microbiota: implications in colon cancer prevention. In: Kongo M (ed) Lactic acid bacteria-R & D for food, health and livestock purposes. InTech, Crotia, 217-242, (2013).
14. Scheppach W., Weiler F. The butyrate story: old wine in new bottles? Curr Opin Clin Nutr Metab Care, 7:563-567, (2004).
15. Sunkata R., Herring J., Walker LT., Verghese M. Chemopreventive potential of probiotics and prebiotics. Food Nutr Sc, 5:1800-1809, (2014).
16. Nurmi J., Puolakkainen P., Rautonen N. Bifidobacterium lactis sp. 420 up-regulates cyclooxygenase (COX) 1 and downregulates COX-2 gene expression in a Caco-2 cell culture model. Nutr Cancer, 51:83-92, (2005).
17. Leu RK., Brown IL., Hu Y., Bird AR., Jackson M., Esterman A., Young GP. A synbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon. J Nutr, 135:996-1001, (2005).
18. Leu RK., Hu Y., Brown IL., Woodman RJ., Young GP. Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis, 31: 246-251, (2010).
19. Lockshin RA., Zakeri Z. Programmed cell death and apoptosis: origins of the theory. Nat Rev Mol Cell Biol, 2:545-550, (2001).
20. Verma A., Shukla G. Probiotics Lactobacillus rhamnosus GG, Lactobacillus acidophilus suppresses DMH-induced procarcinogenic fecal enzymes and preneoplastic aberrant crypt foci in early colon carcinogenesis in Sprague Dawley rats. Nutr Cancer, 65: 84-91, (2013).
21. Verma A., Shukla G. Administration of prebiotic inulin suppresses 1, 2 dimethylhydrazine dihydrochloride induced procarcinogenic biomarkers fecal enzymes and preneoplastic lesions in early colon carcinogenesis in Sprague Dawley rats. J Func Foods, 5:991-996, (2013).
22. Verma A., Shukla G. Synbiotic (Lactobacillus rhamnosus + Lactobacillus acidophilus + inulin) attenuates oxidative stress and colonic damage in 1, 2-dimethylhydrazine dihydrochloride induced colon carcinogenesis in Sprague Dawley rats-a long term study. Eur J Cancer Prev, 23:550-9, (2014).
23. Sanders LM., Henderson CE., Hong MY., Barhoumi R., Burghardt RC., Wang N., Spinka CM., Carroll RJ., Turner ND., Chapkin RS., Lupton JR. An increase in reactive oxygen species by dietary fish oil coupled with the attenuation of antioxidant defenses by dietary pectin enhances rat colonocytes apoptosis. J Nutr, 134:3233-3238, (2004).
24. Guha M., Kumar S., Choubey V., Maity P., Bandyopadhyay U. Apoptosis in liver during malaria: Role of oxidative stress and implication of mitochondrial pathway. FASEB, 20:1224-1226, (2006).
25. Davidson LA., Lupton JR., Jiang YH., Chapkin RS. Carcinogen and dietary lipid regulate ras expression and localization in rat colon without affecting farnesylation kinetics. Carcinogenesis, 20:785-791, (1999).
26. Wu B., Iwakiri R., Ootani A., Tsunada S., Fujise T., Sakata Y., Sakata H., Toda S., Fujimoto K. Dietary corn oil promotes colon cancer by inhibiting mitochondriadependent apoptosis in azoxymethanetreated rats. Exp Biol Med, 229:1017-1025, (2004).
27. Jerusalmi A., Farlow SJ., Sano T. Use of lectin as an anchoring agent for adenovirus-microbead conjugates: Application to the transduction of the inflamed colon in mice. Gene Ther Mol Biol, 10: 223-232, (2006).
28. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science (Washington, DC), 267:1456-1462, (1995).
29. de Moreno de Leblanc A., Matar C., Farnworth E., Perdigón G. Study of immune cells involved in the antitumor effect of kefir in a murine breast cancer model. J Dairy Sci, 90:1920-1928, (2007).
30. Carol M., Borruel N., Antolin M., Llopis M., Casellas F., Guarner F., Malagelada JR. Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease. J Leukoc Biol, 79: 917-922, (2006).
31. Singh J., Rivenson A., Tomita M., Shimamura S., Ishibashi N., Reddy BS. Bifidobacterium longum, a lactic acidproducing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis, 18: 833-84, (1997).
32. Reddy BS. Prevention of colon cancer by pre-and probiotics: evidence from laboratory studies. Br J Nutr, 80: S219-S223, (1998).
33. Kumar M., Verma V., Nagpal R., Kumar A., Gautam SK., Behare PV., Grover CR., Aggarwal PK. Effect of probiotic fermented milk and chlorophyllin on gene expressions and genotoxicity during AFB (1)-induced hepatocellular carcinoma. Gene, 490: 54-59, (2011).
34. Pool-Zobel BL., Neudecker C., Domizlaff I., Ji S., Schillinger U., Rumney C., Moretti M., Vilarini I. Scassellati-Sforzolini R., Rowland I. Lactobacillus and Bifidobacterium mediated antigenotoxicity in the colon of rats. Nutr Cancer, 26: 365-380, (1996).
35. Jiang M., Milner J. Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells. Genes Dev, 17:832-837, (2003).
36. Giacinto CD., Marinaro M., Sanchez M., Strober W., Boirivant M. Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells. J Immunol, 174:3237-3246, (2005).
37. Pohjavuori E., Viljanen M., Korpela R., Kuitunen M., Tiittanen M., Vaarala O., Savilahti E. Lactobacillus GG effect in increasing IFN-γ production in infants with cow's milk allergy. J Allergy Clin Immunol, 114:131-136, (2004).
38. Shida K., Suzuki T., Kiyoshima-Shibata J., Shimada S., Nanno M. Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activity. Clin Vaccine Immunol, 13: 997-1003, (2006).
39. Matsuguchi T., Takagi A., Matsuzaki T., Nagaoka M., Ishikawa K., Yokokura T., Yoshikai Y. Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin Diagn Lab Immunol, 10: 259-266, (2003).
40. Shirota K., LeDuy L., Yuan SY., Jothy S. Interleukin-6 and its receptor are expressed in human intestinal epithelial cells. Virch Archiv B Cell Pathol, 58: 303-308, (1990).
41. Johnson C., Han Y., Hughart N., McCarra J., Alpini G., Meng F. Interleukin-6 and its receptor, key players in hepatobiliary inflammation Interleukin-6 and its receptor, key players in hepatobiliary, inflammation and cancer. Transl Gastrointest Cancer, 1:58-70, (2012).
42. Clarke JO., Mullin GE. A review of complementary and alternative approaches to immunomodulation. Nutr Clin Pract, 23: 49-62, (2008).
43. Villena J., Suzuki R., Fujie H., Chiba E., Takahashi T., Tomosada Y., Shimazu T. Immunobiotic Lactobacillus jensenii modulates the toll-like receptor 4-induced inflammatory response via negative regulation in porcine antigen-presenting cells. Clin Vac Immunol, 19: 1038-1053, (2012).